- Home
- NNVC vs HOOK Comparison
NNVC vs HOOK Comparison
Compare NNVC & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- HOOK
- Stock Information
- Founded
- NNVC 2005
- HOOK 2011
- Country
- NNVC United States
- HOOK United States
- Employees
- NNVC N/A
- HOOK N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- NNVC Health Care
- HOOK Health Care
- Exchange
- NNVC Nasdaq
- HOOK Nasdaq
- Market Cap
- NNVC 22.0M
- HOOK 24.5M
- IPO Year
- NNVC N/A
- HOOK 2019
- Fundamental
- Price
- NNVC $1.50
- HOOK $1.78
- Analyst Decision
- NNVC Strong Buy
- HOOK Buy
- Analyst Count
- NNVC 1
- HOOK 4
- Target Price
- NNVC $6.50
- HOOK $10.67
- AVG Volume (30 Days)
- NNVC 323.3K
- HOOK 44.7K
- Earning Date
- NNVC 02-14-2025
- HOOK 03-21-2025
- Dividend Yield
- NNVC N/A
- HOOK N/A
- EPS Growth
- NNVC N/A
- HOOK N/A
- EPS
- NNVC N/A
- HOOK N/A
- Revenue
- NNVC N/A
- HOOK $49,999,000.00
- Revenue This Year
- NNVC N/A
- HOOK $148.80
- Revenue Next Year
- NNVC N/A
- HOOK N/A
- P/E Ratio
- NNVC N/A
- HOOK N/A
- Revenue Growth
- NNVC N/A
- HOOK 143.30
- 52 Week Low
- NNVC $1.03
- HOOK $1.65
- 52 Week High
- NNVC $3.59
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- NNVC 63.26
- HOOK 41.23
- Support Level
- NNVC $1.30
- HOOK $1.77
- Resistance Level
- NNVC $1.47
- HOOK $1.96
- Average True Range (ATR)
- NNVC 0.11
- HOOK 0.12
- MACD
- NNVC 0.04
- HOOK 0.00
- Stochastic Oscillator
- NNVC 88.37
- HOOK 41.40
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.